Liver Fibrosis SIG NASH Fibrosis: From Matrix to Medicine

This SIG reveals recent progress made in liver fibrosis related to NASH, including new molecular mechanisms and translational aspects of NASH-mediated fibrosis and cirrhosis, and translation of laboratory findings into humans. Speakers will cover significant new information about the potential role of hepatocytes, crosstalk with non-parenchymal cells in NASH-fibrosis, and potential non-invasive biomarkers and treatments of patients with NASH-fibrosis.